Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AbbVie Inc. | 198,423 | reported | 23 May 2022 | tx 92+1,993,056−1,557,738 |
| Avantor, Inc. | 85,821 | reported | 07 May 2026 | tx 8+85,821 |
| Viatris Inc | 0 | reported | 06 Mar 2026 | tx 6+67,033−26,030.46 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 May 2026 | GRANT_AWARD | Avantor, Inc. | 25,270 | 0.00 USD | |
| 06 Mar 2026 | EXERCISE | Viatris Inc | 25,112 | 0.00 USD | |
| 06 Mar 2026 | EXERCISE | Viatris Inc | 919 | 0.00 USD | |
| 06 Mar 2026 | EXERCISE | Viatris Inc | 25,112 | 0.00 USD | deriv |
| 06 Mar 2026 | EXERCISE | Viatris Inc | 918.46 | 0.00 USD | deriv |
| 06 Mar 2026 | GRANT_AWARD | Viatris Inc | 15,890 | 0.00 USD | deriv |
| 12 May 2025 | GRANT_AWARD | Viatris Inc | 25,112 | 0.00 USD | deriv |
| 08 May 2025 | GRANT_AWARD | Avantor, Inc. | 17,100 | 0.00 USD | |
| 09 May 2024 | GRANT_AWARD | Avantor, Inc. | 8,477 | 0.00 USD | |
| 11 May 2023 | GRANT_AWARD | Avantor, Inc. | 9,808 | 0.00 USD | |
| 23 May 2022 | EXERCISE | AbbVie Inc. | 46,320 | 114.36 USD | |
| 23 May 2022 | EXERCISE | AbbVie Inc. | 11,742 | 93.50 USD | |
| 23 May 2022 | EXERCISE | AbbVie Inc. | 21,739 | 105.92 USD | |
| 23 May 2022 | SALE | AbbVie Inc. | 68,196 | 150.79 USD | |
| 23 May 2022 | SALE | AbbVie Inc. | 11,605 | 151.53 USD | |
| 23 May 2022 | EXERCISE | AbbVie Inc. | 21,739 | 105.92 USD | deriv |
| 23 May 2022 | EXERCISE | AbbVie Inc. | 11,742 | 93.50 USD | deriv |
| 23 May 2022 | EXERCISE | AbbVie Inc. | 46,320 | 114.36 USD | deriv |
| 17 May 2022 | SALE | AbbVie Inc. | 2,100 | 155.27 USD | |
| 16 May 2022 | SALE | AbbVie Inc. | 400 | 155.44 USD | anomaly |
| 17 May 2022 | EXERCISE | AbbVie Inc. | 35,364 | 79.02 USD | |
| 17 May 2022 | EXERCISE | AbbVie Inc. | 64,636 | 93.50 USD | |
| 17 May 2022 | SALE | AbbVie Inc. | 43,621 | 153.43 USD | |
| 17 May 2022 | SALE | AbbVie Inc. | 54,279 | 154.49 USD | |
| 16 May 2022 | SALE | AbbVie Inc. | 46,273 | 154.04 USD |